Literature DB >> 16765995

Organ and cell specificity of base excision repair mutants in mice.

Elisabeth Larsen1, Trine J Meza, Liv Kleppa, Arne Klungland.   

Abstract

Genetically modified mouse models are a powerful approach to study the relation of a single gene-deletion to processes such as mutagenesis and carcinogenesis. The generation of base excision repair (BER) deficient mouse models has resulted in a re-examination of the cellular defence mechanisms that exist to counteract DNA base damage. This review discusses novel insights into the relation between specific gene-deletions and the organ and cell specificity of visible and molecular phenotypes, including accumulation of base lesions in genomic DNA and carcinogenesis. Although promising models exist, there is still a need for new models. These models should comprise combined deficiencies of DNA glycosylases which initiate the BER pathway, to elaborate on the repair redundancy, as well as conditional models of the intermediate steps of BER.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16765995     DOI: 10.1016/j.mrfmmm.2006.01.023

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  15 in total

1.  Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice.

Authors:  Lisiane B Meira; Catherine A Moroski-Erkul; Stephanie L Green; Jennifer A Calvo; Roderick T Bronson; Dharini Shah; Leona D Samson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

2.  Age-related instability in spermatogenic cell nuclear and mitochondrial DNA obtained from Apex1 heterozygous mice.

Authors:  Kristine S Vogel; Marissa Perez; Jamila R Momand; Karina Acevedo-Torres; Kim Hildreth; Rebecca A Garcia; Carlos A Torres-Ramos; Sylvette Ayala-Torres; Thomas J Prihoda; C Alex McMahan; Christi A Walter
Journal:  Mol Reprod Dev       Date:  2011-09-14       Impact factor: 2.609

Review 3.  DNA repair dysregulation from cancer driver to therapeutic target.

Authors:  Nicola J Curtin
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

Review 4.  DNA repair mechanisms in Huntington's disease.

Authors:  Ida Jonson; Rune Ougland; Elisabeth Larsen
Journal:  Mol Neurobiol       Date:  2013-01-30       Impact factor: 5.590

Review 5.  Variant base excision repair proteins: contributors to genomic instability.

Authors:  Antonia A Nemec; Susan S Wallace; Joann B Sweasy
Journal:  Semin Cancer Biol       Date:  2010-10-16       Impact factor: 15.707

Review 6.  DNA repair proteins as molecular targets for cancer therapeutics.

Authors:  Mark R Kelley; Melissa L Fishel
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

7.  Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.

Authors:  Melissa L Fishel; Ying He; April M Reed; Helen Chin-Sinex; Gary D Hutchins; Marc S Mendonca; Mark R Kelley
Journal:  DNA Repair (Amst)       Date:  2007-10-31

Review 8.  The role of DNA repair in brain related disease pathology.

Authors:  Chandrika Canugovi; Magdalena Misiak; Leslie K Ferrarelli; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-05-27

Review 9.  Going ape as an approach to cancer therapeutics.

Authors:  Aditi Bapat; Melissa L Fishel; Mark R Kelley
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

10.  Ape1/Ref-1 Stimulates GDNF/GFRalpha1-mediated Downstream Signaling and Neuroblastoma Proliferation.

Authors:  Mi-Young Kang; Kweon Young Kim; Young Yoon; Yoonsung Kang; Hong Beum Kim; Cha Kyung Youn; Dong-Hui Kim; Mi-Hwa Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-10-31       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.